期刊
CLINICAL PHARMACOLOGY & THERAPEUTICS
卷 98, 期 5, 页码 477-479出版社
WILEY-BLACKWELL
DOI: 10.1002/cpt.140
关键词
-
资金
- Centre for Innovation in Regulatory Science, London, UK
- Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, The Netherlands
Timely access to safe and effective new medicines of societal value is a goal of medicine developers, regulators, and payers. However, medicine development remains a costly and time-consuming activity, with median development times in 2013 of 9.9 years for new molecular entities.(1)
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据
分享论文
